Parallel Advisors
SLS icon

Parallel Advisors’s SELLAS Life Sciences SLS Stock Holding History

Parallel Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.02K Buy
+83
New +$1.04K ﹤0.01% 3780

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Parallel Advisors's SLS Position: Q3 2026 in Review

Parallel Advisors opened a new position in SELLAS Life Sciences (SLS) in Q3 2026: 83 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #3780 among its holdings.

67 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Parallel Advisors held 83 shares of SELLAS Life Sciences worth $1.02K as of Q3 2026.
  • SELLAS Life Sciences was a new Parallel Advisors position in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3780 holding.
  • 67 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.